Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors
Clinical Cancer Research (2012) - Comments
pubmed: 22407831  doi: 10.1158/1078-0432.ccr-11-2592  issn: 1078-0432  issn: 1557-3265 

Markus P. Ghadimi, Eric D. Young, Roman Belousov, Yiqun Zhang, Gonzalo Lopez, Kristelle Lusby, Christine Kivlin, Elizabeth G. Demicco, Chad J. Creighton, Alexander J. Lazar, Raphael E. Pollock, Dina Lev